INTRODUCTION. Doxorubicin (Doxo) is a chemotherapeutic agent whose clinical use is hampered by the serious dose-dependent cardiotoxicity. The accumulation of Reactive Oxygen Species (ROS) is widely accepted as a key factor of cardiotoxic effects. Mitochondrial Connexin 43 (Cx43) conferred cardioprotection by reducing cytosolic and mitochondrial ROS production. Topic of this work was the identification of antioxidant enzymes and molecules involved in Doxo-induced damage, in absence and in presence of Radicicol (Rad), an inhibitor of Cx43 translocation to mitochondria. Due to increasing numbers of young cancer survivors and the raising concerns for their fertility state, elucidating the biological mechanisms of chemotherapy risk is highly rel...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
INTRODUCTION: Due to cardiotoxicity, doxorubicin (DOX), a chemotherapeutic agent, has limited use. O...
Oxidative stress is widely accepted as a key factor of doxorubicin (Doxo).induced cardiotoxicity. Th...
Oxidative stress is widely accepted as a key factor of doxorubicin (Doxo).induced cardiotoxicity. Th...
Anthracyclines are among the most utilised antitumour drugs ever developed. The discovery of one of ...
INTRODUCTION. Due to increasing numbers of young cancer survivors, the understanding of the biologic...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
AbstractThe utility of anthracycline antineoplastic agents in the clinic is compromised by the risk ...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
INTRODUCTION: Due to cardiotoxicity, doxorubicin (DOX), a chemotherapeutic agent, has limited use. O...
Oxidative stress is widely accepted as a key factor of doxorubicin (Doxo).induced cardiotoxicity. Th...
Oxidative stress is widely accepted as a key factor of doxorubicin (Doxo).induced cardiotoxicity. Th...
Anthracyclines are among the most utilised antitumour drugs ever developed. The discovery of one of ...
INTRODUCTION. Due to increasing numbers of young cancer survivors, the understanding of the biologic...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of cardi...
Doxorubicin (Dox) is one of the most potent anti-neoplastic agents approved by the Food and Drug Adm...
AbstractThe utility of anthracycline antineoplastic agents in the clinic is compromised by the risk ...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
Doxorubicin is the highly effective anthracycline, but its clinical use is limited by cardiotoxicity...
INTRODUCTION: Due to cardiotoxicity, doxorubicin (DOX), a chemotherapeutic agent, has limited use. O...